Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2465)
All Articles published online
|
Dec 21, 2005 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zou MJ, Cheng G, Okamoto H, Hao XH, An F, Cui FD, Danjo K. Colon-specific drug delivery systems based on cyclodextrin prodrugs: In vivo evaluation of 5-aminosalicylic acid from its cyclodextrin conjugates. World J Gastroenterol 2005; 11(47): 7457-7460 [PMID: 16437716 DOI: 10.3748/wjg.v11.i47.7457] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i47/7457.htm |
| Number | Citing Articles |
| 1 |
Majid Y. Moridani. Prodrugs and Targeted Delivery. Methods and Principles in Medicinal Chemistry 2010; 47: 207 doi: 10.1002/9783527633166.ch9
|
| 2 |
Noemi Bognanni, Francesco Bellia, Graziella Vecchio. Cyclodextrin Polymers Functionalized with Histidine and Carcinine as Chelating Therapeutics for Copper Dyshomeostasis. ChemMedChem 2023; 18(13) doi: 10.1002/cmdc.202300035
|
| 3 |
Paulo José Salústio, Patrícia Pontes, Claúdia Conduto, Inês Sanches, Catarina Carvalho, João Arrais, Helena M. Cabral Marques. Advanced Technologies for Oral Controlled Release: Cyclodextrins for Oral Controlled Release. AAPS PharmSciTech 2011; 12(4): 1276 doi: 10.1208/s12249-011-9690-2
|
| 4 |
Tamaki Takagi, Tomiyasu Arisawa, Kazumasa Yamamoto, Ichiro Hirata, Hiroshi Nakano, Makoto Sawada. IDENTIFICATION OF LIGANDS BINDING SPECIFICALLY TO INFLAMMATORY INTESTINAL MUCOSA USING PHAGE DISPLAY. Clinical and Experimental Pharmacology and Physiology 2007; 34(4): 286 doi: 10.1111/j.1440-1681.2007.04563.x
|
| 5 |
Rajiv Sharma, Ravindra K. Rawal, Tripti Gaba, Nishu Singla, Manav Malhotra, Sahil Matharoo, T.R. Bhardwaj. Design, synthesis and ex vivo evaluation of colon-specific azo based prodrugs of anticancer agents. Bioorganic & Medicinal Chemistry Letters 2013; 23(19): 5332 doi: 10.1016/j.bmcl.2013.07.059
|
| 6 |
Angel Concheiro, Carmen Alvarez-Lorenzo. Chemically cross-linked and grafted cyclodextrin hydrogels: From nanostructures to drug-eluting medical devices. Advanced Drug Delivery Reviews 2013; 65(9): 1188 doi: 10.1016/j.addr.2013.04.015
|
| 7 |
Sahil Kumar, Bandna Sharma, Tilak R. Bhardwaj, Rajesh K. Singh. Design, Synthesis and Studies on Novel Polymeric Prodrugs of Erlotinib for Colon Drug Delivery. Anti-Cancer Agents in Medicinal Chemistry 2021; 21(3): 383 doi: 10.2174/1871520620666200811124013
|
| 8 |
Hossein Shahdadi Sardo, Farinaz Saremnejad, Sara Bagheri, Abbas Akhgari, Hadi Afrasiabi Garekani, Fatemeh Sadeghi. A review on 5-aminosalicylic acid colon-targeted oral drug delivery systems. International Journal of Pharmaceutics 2019; 558: 367 doi: 10.1016/j.ijpharm.2019.01.022
|
| 9 |
C.A. Schoener, N.A. Peppas. Oral delivery of chemotherapeutic agents: background and potential of drug delivery systems for colon delivery. Journal of Drug Delivery Science and Technology 2012; 22(6): 459 doi: 10.1016/S1773-2247(12)50081-X
|
| 10 |
Manish Dhall, A. K. Madan. Comparison of cyclodextrins and urea as hosts for inclusion of drugs. Journal of Inclusion Phenomena and Macrocyclic Chemistry 2017; 89(3-4): 207 doi: 10.1007/s10847-017-0748-y
|
| 11 |
Stefano Salmaso, Fabio Sonvico. Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine. 2011; : 251 doi: 10.1002/9780470926819.ch13
|
| 12 |
Zahra Vaezi, Shaghayegh Baradaran Ghavami, Maryam Farmani, Reza Mahdavian, Hamid Asadzadeh Aghdaei, Hossein Naderi-Manesh. Oral Formulation of 5-Aminosalicylic Acid-Hemoglobin Bio-Adhesive Nanoparticles Enhance Therapeutic Efficiency in Ulcerative Colitis Mice: A Preclinical Evaluation. Journal of Pharmaceutical Sciences 2024; doi: 10.1016/j.xphs.2024.03.028
|
| 13 |
Steven Neau. Water-Insoluble Drug Formulation, Second Edition. 2008; : 437 doi: 10.1201/9781420009552.ch16
|
| 14 |
Yanhong Wu, Shangyong Li, Mengfei Jin, Dandan Li, Zihan Zhou, Haiqing Hou, Yantao Han. Preparation of MSZ Hydrogel and Its Treatment of Colitis. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.706401
|
| 15 |
Christian Lautenschläger, Carsten Schmidt, Dagmar Fischer, Andreas Stallmach. Drug delivery strategies in the therapy of inflammatory bowel disease. Advanced Drug Delivery Reviews 2014; 71: 58 doi: 10.1016/j.addr.2013.10.001
|
| 16 |
Hamid A. Bakshi, Gerry A. Quinn, Alaa A. A. Aljabali, Faruck L. Hakkim, Rabia Farzand, Mohamed M. Nasef, Naji Abuglela, Prawej Ansari, Vijay Mishra, Ángel Serrano-Aroca, Murtaza M. Tambuwala. Exploiting the Metabolism of the Gut Microbiome as a Vehicle for Targeted Drug Delivery to the Colon. Pharmaceuticals 2021; 14(12): 1211 doi: 10.3390/ph14121211
|
| 17 |
Mengchi Sun, Weiyue Ban, Hao Ling, Xiang Yu, Zhonggui He, Qikun Jiang, Jin Sun. Emerging nanomedicine and prodrug delivery strategies for the treatment of inflammatory bowel disease. Chinese Chemical Letters 2022; 33(10): 4449 doi: 10.1016/j.cclet.2022.03.061
|
| 18 |
Hui Min Chu, Rui Xia Zhang, Qing Huang, Chang Cai Bai, Zhi Zhong Wang. Chemical conjugation with cyclodextrins as a versatile tool for drug delivery. Journal of Inclusion Phenomena and Macrocyclic Chemistry 2017; 89(1-2): 29 doi: 10.1007/s10847-017-0743-3
|
| 19 |
Amal H. El-Kamel, Alaa A.-M. Abdel-Aziz, Amal J. Fatani, Hussein I. El-Subbagh. Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: Synthesis, in vitro and in vivo assessment. International Journal of Pharmaceutics 2008; 358(1-2): 248 doi: 10.1016/j.ijpharm.2008.04.021
|
| 20 |
Francesco Bellia, Diego La Mendola, Carlo Pedone, Enrico Rizzarelli, Michele Saviano, Graziella Vecchio. Selectively functionalized cyclodextrins and their metal complexes. Chemical Society Reviews 2009; 38(9): 2756 doi: 10.1039/b718436k
|